These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 26147609

  • 1. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
    Oldfield EH, Vance ML, Louis RG, Pledger CL, Jane JA, Lopes MB.
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
    [Abstract] [Full Text] [Related]

  • 2. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
    Cordeiro D, Xu Z, Nasser M, Lopes B, Vance ML, Sheehan J.
    J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
    [Abstract] [Full Text] [Related]

  • 3. Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs.
    Eschbacher JM, Coons SW.
    Endocr Pathol; 2006 Mar; 17(4):365-76. PubMed ID: 17525485
    [Abstract] [Full Text] [Related]

  • 4. Surgical pathology of the pituitary in Cushing's disease.
    Saeger W.
    Pathol Res Pract; 1991 Jun; 187(5):613-6. PubMed ID: 1656411
    [Abstract] [Full Text] [Related]

  • 5. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
    Roncaroli F, Faustini-Fustini M, Mauri F, Asioli S, Frank G.
    Endocr Pathol; 2002 Jun; 13(3):245-9. PubMed ID: 12446925
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review.
    Zhu D, Wang Z, Tian T, Wu X, He D, Zhu Y, Liu D, Wang H.
    Front Endocrinol (Lausanne); 2022 Jun; 13():947085. PubMed ID: 36060980
    [Abstract] [Full Text] [Related]

  • 7. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
    Tanaka S, Yamamoto M, Morita M, Takeno A, Kanazawa I, Yamaguchi T, Yamada S, Inoshita N, Oki Y, Kurosaki M, Sugimoto T.
    Endocr J; 2019 Aug 29; 66(8):701-708. PubMed ID: 31130573
    [Abstract] [Full Text] [Related]

  • 8. Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease.
    Akirov A, Larouche V, Shimon I, Asa SL, Mete O, Sawka AM, Gentili F, Ezzat S.
    Front Endocrinol (Lausanne); 2021 Aug 29; 12():620005. PubMed ID: 33815279
    [Abstract] [Full Text] [Related]

  • 9. Current status on histological classification in Cushing's disease.
    Syro LV, Rotondo F, Cusimano MD, Di Ieva A, Horvath E, Restrepo LM, Wong M, Killinger DW, Smyth H, Kovacs K.
    Pituitary; 2015 Apr 29; 18(2):217-24. PubMed ID: 25501318
    [Abstract] [Full Text] [Related]

  • 10. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland.
    Taylor HC, Velasco ME, Brodkey JS.
    Arch Intern Med; 1980 Oct 29; 140(10):1366-8. PubMed ID: 6252859
    [Abstract] [Full Text] [Related]

  • 11. Pituitary pathology in Cushing's disease.
    Saeger W, Geisler F, Lüdecke DK.
    Pathol Res Pract; 1988 Sep 29; 183(5):592-5. PubMed ID: 3237549
    [Abstract] [Full Text] [Related]

  • 12. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 29; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 13. Prognostic indicators in an aggressive pituitary Crooke's cell adenoma.
    Kovacs K, Diep CC, Horvath E, Cusimano M, Smyth H, Lombardero CC, Scheithauer BW, Lloyd RV.
    Can J Neurol Sci; 2005 Nov 29; 32(4):540-5. PubMed ID: 16408589
    [Abstract] [Full Text] [Related]

  • 14. Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing's disease.
    Flitsch J, Lüdecke DK, Knappe UJ, Saeger W.
    Exp Clin Endocrinol Diabetes; 1999 Nov 29; 107(3):183-9. PubMed ID: 10376443
    [Abstract] [Full Text] [Related]

  • 15. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
    George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF, Lloyd RV, Meyer FB.
    Am J Surg Pathol; 2003 Oct 29; 27(10):1330-6. PubMed ID: 14508394
    [Abstract] [Full Text] [Related]

  • 16. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
    Reincke M, Ritzel K, Oßwald A, Berr C, Stalla G, Hallfeldt K, Reisch N, Schopohl J, Beuschlein F.
    Eur J Endocrinol; 2015 Oct 29; 173(4):M23-32. PubMed ID: 25994948
    [Abstract] [Full Text] [Related]

  • 17. Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease.
    Hague K, Post KD, Morgello S.
    Surg Neurol; 2000 Jan 29; 53(1):77-81. PubMed ID: 10697237
    [Abstract] [Full Text] [Related]

  • 18. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
    Kurowska M, Tarach JS, Malicka J, Zieliński G, Maksymowicz M, Denew P.
    Endokrynol Pol; 2016 Jan 29; 67(5):526-533. PubMed ID: 27828691
    [Abstract] [Full Text] [Related]

  • 19. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
    Takeshita A, Inoshita N, Taguchi M, Okuda C, Fukuhara N, Oyama K, Ohashi K, Sano T, Takeuchi Y, Yamada S.
    Eur J Endocrinol; 2009 Oct 29; 161(4):553-9. PubMed ID: 19589911
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
    Sahli R, Christ ER, Seiler R, Kappeler A, Vajtai I.
    Pathol Res Pract; 2006 Oct 29; 202(6):457-64. PubMed ID: 16497445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.